Improved Drug Susceptibility Testing (DST) for Mycobacteria

Skip to main content

Contracts Grants Pricing Blog Glossary

Loading...

Kontrakk

The only workspace built for the work of government contracting.

Platform

Discovery feed
Pursuit board
Grants

Industries

Federal contractors
Defense primes
Nonprofit grants
Higher education

Resources

Help center
Developer docs

Company

About
Privacy
Terms of Service

© 2026 Kontrakk. All rights reserved.Government Contracts. Won with Confidence.

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Home
Grants
Improved Drug Susceptibility Testing (DST) for Mycobacteria

Improved Drug Susceptibility Testing (DST) for Mycobacteria

forecasted

forecast

#RFA-AI-28-018

Agency

National Institutes of Health

Code: HHS-NIH11

Description

No description available

Important Dates

Open Date

Jun 24, 2026

CFDA Numbers

93.855

View on Grants.gov

More grants from National Institutes of Health

Investigator-Focused Award (Parent R35)
National Institutes of Health
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)
National Institutes of Health
Clinical and Translational Science Award
National Institutes of Health
Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program
National Institutes of Health